Hjem › Spinal muskelatrofi › Arkansas › Little Rock
Kliniske studier for Spinal muskelatrofi i Little Rock, AR
4 studier for Spinal muskelatrofi søker deltakere på steder i og rundt Little Rock (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
RekruttererFase 4
- University of Arkansas for Medical Sciences, Little Rock
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
RekruttererFase 2
- Arkansas Children's Hospital, Little Rock
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
RekruttererFase 4
- University of Arkansas for Medical Sciences, Little Rock
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
RekruttererObservasjonsstudie
- Arkansas Children's Hospital, Little Rock
Spinal muskelatrofi-studier i andre byer
- New York City, NY9 studier
- Mountain View, CA9 studier
- Philadelphia, PA7 studier
- Grand Rapids, MI6 studier
- Chicago, IL6 studier
- Norfolk, VA6 studier
- Houston, TX5 studier
- Boston, MA5 studier
- Phoenix, AZ4 studier
- Lewisville, TX4 studier
- Aurora, CO4 studier
- Memphis, TN3 studier
Andre studier i Little Rock
- Schizofreni19 studier
- Kreft (alle typer)14 studier
- Major depresjon14 studier
- Akut myelogen leukemi13 studier
- Ikke-småcellet lungekreft13 studier
- Fedme11 studier
- Endometriekreft10 studier
- Depresjon10 studier
- Type 2-diabetes10 studier
- Lungekreft9 studier
- Kardiovaskulær sykdom9 studier
- Blærekreft9 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.